ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0413

Improving Access to Timely Joint Injections for Pediatric Rheumatology Patients – A Quality Improvement Initiative

Kendra Lauer1, Vidya Sivaraman2, Melissa Argraves3, Ysabella Esteban4, Laura Pratt5, Alysha Taxter6, Shoghik Akoghlanian3, Kelly Wise7, Kathryn Anliker3, Jonnie Hughes3, James Booker3, Ashlee Leone3 and Edward Oberle3, 1Nationwide Children's Hospital, Dublin, OH, 2Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 3Nationwide Children's Hospital, Columbus, OH, 4Nationwide Children's Hospital, Plain City, OH, 5Nationwide Children's Hospital/The Ohio State University College of Medicine, Columbus, OH, 6Nationwide Children's, Columbus, OH, 7Nationwide Children's Hospital, Hilliard, OH

Meeting: ACR Convergence 2025

Keywords: Access to care, corticosteroids, Juvenile idiopathic arthritis, Pediatric rheumatology, quality of care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0387–0429) Pediatric Rheumatology – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Timely treatment for juvenile idiopathic arthritis (JIA) is essential for disease remission and decreasing risk of long-term morbidity. Intra-articular corticosteroid joint injections can treat active arthritis. If a joint injection cannot be completed in the outpatient clinic due to sedation needs, additional steps must be made to schedule the procedure, often delaying treatment. Using quality improvement (QI) methodology, this study aims to reduce the time to completion of joint injection for patients in our pediatric rheumatology clinic.

Methods: Our QI team reviewed all clinic encounters of JIA patients from September 2023 to March 2025. We obtained a baseline number of joint injections per month for the initial 8 months and the percentage of those that were completed within 30 days. A new monthly joint injection clinic was started in collaboration with the surgery center for sedated joint injections. Scheduling processes for joint injections were implemented as standardized forms for nursing and provider workflows within the electronic health record (EHR). The number of patients receiving joint injections and the time to completion were tracked monthly using control charts. To further evaluate the new workflows, a survey was administered to providers, trainees, and nurses.

Results: During the study period, 166 patients received joint injections, and 137 (82%) were completed within 30 days. During the baseline period, there was a mean completion rate of 90%. As we continued standardization processes and implementing interventions, there was a decrease in joint injections completed in 30 days resulting in a new process stage mean of 74% (Figure 1). When looking at average number of days until joint injection completion, the initial baseline mean was 12 days but increased to 20 days after the new process stage mean was established. The median average of days until injection completion was 15.5 days (Figure 2). Factors contributing to decrease in mean included: 1) transition to a new surgery center location in May 2024 and 2) decreased availability of sedated procedures over the holiday months of November- December 2024. Provider and staff survey results showed agreement that our new workflows have streamlined communication for details of the procedures to surgery center staff, simplified the scheduling process, decreased the number of messages needed to schedule procedures, and increased the procedure opportunities for fellow trainees. Respondents felt that length of time to schedule a joint injection was closely split between decreased (46%) and no difference (47%) (Figure 3).

Conclusion: This ongoing QI study demonstrates that implementation of a standardized form used by nursing and physician workflows within the EHR helped create a streamlined process for scheduling and completing corticosteroid joint injections within a 30-day window.

Supporting image 1Figure 1: Control chart showing percentage of joint injections completed per month.

Supporting image 2Figure 2: Control chart showing number of days for joint injections to be completed per month.

Supporting image 3Figure 3: Survey results regarding usefulness of standardized form for joint injections within the electronic health record.


Disclosures: K. Lauer: None; V. Sivaraman: None; M. Argraves: None; Y. Esteban: None; L. Pratt: None; A. Taxter: None; S. Akoghlanian: None; K. Wise: None; K. Anliker: None; J. Hughes: None; J. Booker: None; A. Leone: None; E. Oberle: Pfizer, 1.

To cite this abstract in AMA style:

Lauer K, Sivaraman V, Argraves M, Esteban Y, Pratt L, Taxter A, Akoghlanian S, Wise K, Anliker K, Hughes J, Booker J, Leone A, Oberle E. Improving Access to Timely Joint Injections for Pediatric Rheumatology Patients – A Quality Improvement Initiative [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/improving-access-to-timely-joint-injections-for-pediatric-rheumatology-patients-a-quality-improvement-initiative/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-access-to-timely-joint-injections-for-pediatric-rheumatology-patients-a-quality-improvement-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology